CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $962,000 | -0.9% | 201,265 | -5.2% | 0.00% | – |
| Q2 2021 | $971,000 | +20.6% | 212,398 | +36.5% | 0.00% | -100.0% |
| Q1 2021 | $805,000 | -11.0% | 155,609 | +11.1% | 0.00% | 0.0% |
| Q4 2020 | $904,000 | +17980.0% | 140,107 | +13595.7% | 0.00% | – |
| Q3 2020 | $5,000 | -50.0% | 1,023 | -39.3% | 0.00% | – |
| Q2 2020 | $10,000 | – | 1,686 | +10437.5% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 16 | -90.5% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 168 | +104.9% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 82 | -2.4% | 0.00% | – |
| Q2 2018 | $1,000 | -98.8% | 84 | -99.0% | 0.00% | – |
| Q1 2017 | $80,000 | – | 8,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |